UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders

Current vascular pharmacology, 2016-05, Vol.14 (3), p.280

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa

Current drug metabolism, 2011-01, Vol.12 (1), p.51

2011

Link zum Volltext

Verfügbarkeit prüfen

Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations

Journal of Drug Delivery, 2016-01, Vol.2016, p.3810175-10

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Atazanavir Oral Absorption by Lansoprazole Gastric Acid Suppression in Healthy Volunteers

Pharmacotherapy, 2006-03, Vol.26 (3), p.341-346

2006

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of an LC–MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid

Journal of pharmaceutical and biomedical analysis, 2018-07, Vol.156, p.163-169

2018

Link zum Volltext

Verfügbarkeit prüfen

Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories

Antimicrobial Agents and Chemotherapy, 2004-03, Vol.48 (3), p.824-831

2004

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

Pharmacogenetics and genomics, 2012-12, Vol.22 (12), p.858-867

2012

Link zum Volltext

Verfügbarkeit prüfen

In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to Macrophages

Pharmaceutical research, 2019-03, Vol.36 (3), p.44-8, Article 44

2019

Link zum Volltext

Verfügbarkeit prüfen

Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study

Pharmacogenetics and genomics, 2006-11, Vol.16 (11), p.837-845

2006

Link zum Volltext

Verfügbarkeit prüfen

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2175-2182

2014

Link zum Volltext

Verfügbarkeit prüfen

Sources of Variability and Accuracy of Performance Assessment in the Clinical Pharmacology Quality Assurance Proficiency Testing Program for Antiretrovirals

Therapeutic drug monitoring, 2019-08, Vol.41 (4), p.452

2019

Link zum Volltext

Verfügbarkeit prüfen

Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines

Pharmaceutical research, 2019-01, Vol.36 (1), p.8-15, Article 8

2019

Link zum Volltext

Verfügbarkeit prüfen

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202

Pharmacogenetics and genomics, 2014-04, Vol.24 (4), p.195-203

2014

Link zum Volltext

Verfügbarkeit prüfen

Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s

Antiviral therapy, 2018-01, Vol.23 (4), p.345-351

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of Dolutegravir and Sertraline on the Blood Brain Barrier (BBB)

Journal of neuroimmune pharmacology, 2020-03, Vol.15 (1), p.7-9

2020

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

British journal of clinical pharmacology, 2020-01, Vol.86 (1), p.132-142

2020

Link zum Volltext

Verfügbarkeit prüfen

Compartmental Pharmacokinetic Analysis of Oral Amprenavir with Secondary Peaks

Antimicrobial Agents and Chemotherapy, 2007-05, Vol.51 (5), p.1822-1826

2007

Link zum Volltext

Verfügbarkeit prüfen

Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202

Pharmacogenetics and genomics, 2015-09, Vol.25 (9), p.450-461

2015

Link zum Volltext

Verfügbarkeit prüfen

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events

Pharmacogenetics and genomics, 2018-07, Vol.28 (7), p.179-187

2018

Link zum Volltext

Verfügbarkeit prüfen

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202

Pharmacogenetics and genomics, 2017-03, Vol.27 (3), p.101-111

2017

Link zum Volltext

Verfügbarkeit prüfen

Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s

Journal of antimicrobial chemotherapy, 2017-07, Vol.72 (7), p.2042-2048

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics of CYP3A: considerations for HIV treatment

Pharmacogenomics, 2009-08, Vol.10 (8), p.1323

2009

Link zum Volltext

Verfügbarkeit prüfen

Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Link zum Volltext

Verfügbarkeit prüfen

Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy

Antimicrobial agents and chemotherapy, 2015-12, Vol.59 (12), p.7852-7856

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratories

Therapeutic drug monitoring, 2013-10, Vol.35 (5), p.631

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(101)
Science & Technology
(101)
Humans
(88)
Biological And Medical Sciences
(57)
Medical Sciences
(57)
Pharmacology. Drug Treatments
(55)
Adult
(50)
Female
(50)
Male
(50)
Hiv Infections - Drug Therapy
(37)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(35)
Antiviral Agents
(32)
Middle Aged
(30)
Human Immunodeficiency Virus
(25)
Infectious Diseases
(23)
Aids/hiv
(21)
Hiv
(20)
Microbiology
(19)
Anti-Hiv Agents - Pharmacokinetics
(18)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders

Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa

Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations

Inhibition of Atazanavir Oral Absorption by Lansoprazole Gastric Acid Suppression in Healthy Volunteers

Development and validation of an LC–MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid

Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to Macrophages

Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

Sources of Variability and Accuracy of Performance Assessment in the Clinical Pharmacology Quality Assurance Proficiency Testing Program for Antiretrovirals

Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202

Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s

Effect of Dolutegravir and Sertraline on the Blood Brain Barrier (BBB)

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

Compartmental Pharmacokinetic Analysis of Oral Amprenavir with Secondary Peaks

Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202

Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s

Pharmacogenomics of CYP3A: considerations for HIV treatment

Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques

Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy

Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratories

Aktive Filter

Suchergebnisse filtern